Table 2.
Compound | Concentration (µg/mL) | Percentage of infected macrophages after treatment | Infectiveness reduction (%) | Number of amastigotes per macrophage |
---|---|---|---|---|
Acarbose | 10.0 | 9.4 ± 0.7 | 87.4 | 0.1 ± 0 |
5.0 | 19.8 ± 2.6 | 73.4 | 0.5 ± 0.2 | |
2.5 | 33.4 ± 5.4 | 55.1 | 1.4 ± 0.3 | |
0 | 74.4 ± 5.5 | (–) | 3.3 ± 0.6 | |
Amphotericin B | 1.0 | 24.2 ± 3.0 | 67.5 | 1.1 ± 0.2 |
0.50 | 33.6 ± 4.0 | 54.8 | 1.8 ± 0.3 | |
0.25 | 49.9 ± 3.5 | 32.9 | 2.6 ± 0.6 | |
0 | 74.4 ± 5.5 | (–) | 3.3 ± 0.6 |
Murine macrophages (5 × 105 cells) were incubated in RPMI 1640 medium supplemented with 20% FBS and 20 mM l-glutamine at pH 7.4, for 24 h at 37 °C in 5% CO2. L. infantum stationary promastigotes were used to infect the macrophages (at a ratio of 10 parasites per one macrophage) for 48 h at 37 °C in 5% CO2. Free parasites were removed by extensive washing with medium and infected macrophages were treated with ACA (0, 2.5, 5.0 and 10.0 µg/mL) or AmpB (0, 0.25, 0.5 and 1.0 µg/mL) for 48 h at 24 °C in 5% CO2. Percentage of infected macrophages, infectiveness reduction and the number of recovered amastigotes per cell were determined by counting 200 macrophages, in triplicate. Results are expressed as mean ± standard deviation